Black Health
NSAID Pain Inflammation Menstrual cramps Gout flare Arthritis

Naproxen (Aleve, Naprosyn, Anaprox) and Black patients

Brand names: Aleve, Naprosyn, Anaprox

Last reviewed: Sources checked:

What Naproxen does

Naproxen is a longer-acting NSAID; twice-daily dosing works for most indications versus ibuprofen's 6–8 hour window. It has the most favorable cardiovascular safety profile of the non-selective NSAIDs, per large PRECISION-style trial analyses.

What the evidence says for Black patients

Naproxen's CV profile (compared to ibuprofen or celecoxib) makes it the preferred NSAID for patients at elevated cardiovascular risk — a group that includes a disproportionate share of Black adults with hypertension, diabetes, or existing heart disease.

All other NSAID cautions apply: BP rise, kidney injury risk, GI bleeding, interaction with ACE-i/ARB. The practical implications for Black patients match those described on the ibuprofen page — with the cardiovascular argument slightly favoring naproxen for chronic use when an NSAID is needed.

Pain under-treatment bias (Hoffman et al., 2016) applies equally here. Naproxen being offered does not exempt a clinician from evaluating whether an opioid or alternative stronger analgesic is clinically warranted.

Common alternatives

Ibuprofen, celecoxib (COX-2-selective, less GI risk, higher CV risk historically — though 2016 PRECISION trial narrowed that gap), topical diclofenac, acetaminophen.

Side effects

  • GI ulcers/bleeding — higher than ibuprofen at equipotent doses
  • Elevated BP
  • Kidney injury
  • Fluid retention
  • CV events (lower than other NSAIDs per PRECISION)
  • Bronchospasm in aspirin-sensitive asthma

Factors that affect adherence

Take with food; consider adding a PPI (omeprazole) for long-term use or in patients over 60. OTC cost is modest.

Questions to ask your doctor

Bring this list to your next appointment.

  • If I'm at elevated cardiovascular risk, is naproxen the best choice among NSAIDs?
  • Should I be on a PPI at the same time?
  • If I need long-term pain control, are there non-NSAID options for me?

References

  1. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis (PRECISION). NEJM. 2016;375:2519–2529. PMID 27959710.
  2. Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data. Lancet. 2013;382:769–779.
  3. U.S. Food and Drug Administration. Naprosyn (naproxen) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017581s125lbl.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.